Search / 520 results found

from
to

SEATTLE, June 9, 2021 /PRNewswire/ -- OnQuality Pharmaceuticals ("OnQuality"), a targeted cancer supportive care company developing medications to address specific side effects and improve the quality of life for patients receiving anti-cancer medications, today announced that it has been selected to deliver a company presentation at the Biotechnology Innovation Organization (BIO)'s 2021 BIO Digital International Convention, being held virtually June 10-11 and 14-18, 2021.

SEATTLE, June 1, 2021 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for pacritinib as a treatment for myelofibrosis patients with severe thrombocytopenia (platelet counts less than 50 x 109/L), with the NDA being granted Priority Review. The Prescription Drug User Fee Act (PDUFA) target action date is November 30, 2021. The FDA is not currently planning to hold an advisory committee meeting to discuss the NDA.

Dairy cows are most susceptible to new intramammary infections during the dry period. Infection acquired during that period can have a significant impact on milk production, milk quality, herd removal and reproductive performance post-calving. Here are eight prevention strategies that can help reduce the risk that new intramammary infections develop post-calving.